je.st
news
Tag: phase
State Approves UK, EdR Plan for $101M Student Housing Phase
2013-05-24 06:17:00| National Real Estate Investor
The partnership of the company and the school has already produced almost 3,000 new beds. read more
Tags: state
plan
student
phase
Merck Provides Update on Phase III Clinical Program for Preladenant, the Companys Investigational Parkinsons Disease Medicine
2013-05-23 23:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided an update on the clinical program for preladenant, Mercks investigational adenosine A2A receptor antagonist for the treatment of Parkinsons disease (PD). An initial review of data from three separate Phase III trials did not provide evidence of efficacy for preladenant compared with placebo. Language: English Contact HTML: MerckMedia Contacts:Pam Eisele, 908-423-5042orClaire Mulhearn, 908-423-7425orInvestor Contacts:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: program
iii
update
medicine
Taylor Woodrow wins Croxley rail link phase one contract
2013-05-23 01:00:00| Railway Technology
Taylor Woodrow, part of Vinci Construction, has won a contract from Hertfordshire County Council in the UK to carry out the design and planning stage of the 118m Croxley Rail Link project.
Tags: link
contract
phase
taylor
Cupertino Electric Completes First Phase of 21-Site Solar Project
2013-05-21 18:35:00| Electrical Construction & Maintenance
The Energy Alternatives Division of Cupertino Electric has completed the first phase of a parking lot canopy and playground shade structure-based solar system for California's Clovis Unified School District read more
Tags: project
phase
electric
solar
MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation ...
2013-05-21 14:59:03| Logistics - Topix.net
MacroGenics Announces Margetuximab Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer MacroGenics Announces Margetuximab Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic ... (more)
Tags: data
phase
presentation
announces
Sites : [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] next »